基本情報

写真a

山崎　雅子(ヤマサキ　マサコ)

YAMASAKI Masako


職名

助教
このページの先頭へ▲

経歴(学内) 【 表示 ／ 非表示 】

  • 2025年04月
    -
    現在
    東京科学大学 教育研究組織 総合研究院 難治研・未来科学研究部門 人体模倣システム学分野 助教
このページの先頭へ▲
 

論文・総説 【 表示 ／ 非表示 】

  1. Yamasaki M, Saso W, Yamamoto T, Sato M, Takagi H, Hasegawa T, Kozakura Y, Yokoi H, Ohashi H, Tsuchimoto K, Hashimoto R, Fukushi S, Uda A, Muramatsu M, Takayama K, Maeda K, Takahashi Y, Nagase T, Watashi K. Anti-SARS-CoV-2 gapmer antisense oligonucleotides targeting the main protease region of viral RNA. Antiviral research. 2024.10; 230 105992. ( PubMed, DOI )

  2. Ohashi Hirofumi, Nishioka Kazane, Kurihara Tomoki, Nakamura Kou, Yamasaki Masako, Ibayashi Yuuka, Fuchiyama Kanta, Kamo Shogo, Furuyama Yuuki, Ohgane Kenji, Okada Maiko, Kamisuki Shinji, Watashi Koichi, Kuramochi Kouji. ジュグロルビン誘導体の抗C型肝炎ウイルス活性(Anti-hepatitis C Virus Activity of Juglorubin Derivatives) Chemical & Pharmaceutical Bulletin. 2023.11; 71 (11): 843-845. ( 医中誌 )

  3. Nakamura Kou, Yamasaki Masako, Ohashi Hirofumi, Saito Shiki, Ashikawa Koudai, Sato Kanna, Nishioka Kazane, Suzuki Yuka, Tsurukawa Yukine, Kanno Kazuki, Mosu Nozomi, Murakami Hironobu, Nagane Masaki, Okada Maiko, Watashi Koichi, Kamisuki Shinji. アリール炭化水素受容体に対する部分アゴニストとしてのメチルスロクリンの同定とその抗ウイルスおよび抗炎症活性(Identification of Methylsulochrin as a Partial Agonist for Aryl Hydrocarbon Receptors and Its Antiviral and Anti-inflammatory Activities) Chemical & Pharmaceutical Bulletin. 2023.08; 71 (8): 650-654. ( 医中誌 )

  4. Nakamura K, Yamasaki M, Ohashi H, Saito S, Ashikawa K, Sato K, Nishioka K, Suzuki Y, Tsurukawa Y, Kanno K, Mosu N, Murakami H, Nagane M, Okada M, Watashi K, Kamisuki S. Identification of Methylsulochrin as a Partial Agonist for Aryl Hydrocarbon Receptors and Its Antiviral and Anti-inflammatory Activities. Chemical & pharmaceutical bulletin. 2023.08; 71 (8): 650-654. ( PubMed, DOI )

  5. Saso W, Yamasaki M, Nakakita SI, Fukushi S, Tsuchimoto K, Watanabe N, Sriwilaijaroen N, Kanie O, Muramatsu M, Takahashi Y, Matano T, Takeda M, Suzuki Y, Watashi K. Significant role of host sialylated glycans in the infection and spread of severe acute respiratory syndrome coronavirus 2. PLoS pathogens. 2022.06; 18 (6): e1010590. ( PubMed, DOI )

  6. Kobayashi C, Watanabe Y, Oshima M, Hirose T, Yamasaki M, Iwamoto M, Iwatsuki M, Asami Y, Kuramochi K, Wakae K, Aizaki H, Muramatsu M, Sureau C, Sunazuka T, Watashi K. Fungal Secondary Metabolite Exophillic Acid Selectively Inhibits the Entry of Hepatitis B and D Viruses. Viruses. 2022.04; 14 (4): ( PubMed, DOI )

  7. Nishiuchi K, Ohashi H, Nishioka K, Yamasaki M, Furuta M, Mashiko T, Tomoshige S, Ohgane K, Kamisuki S, Watashi K, Kuramochi K. Synthesis and Antiviral Activities of Neoechinulin B and Its Derivatives. Journal of natural products. 2022.01; 85 (1): 284-291. ( PubMed, DOI )

  8. Ohashi H, Wang F, Stappenbeck F, Tsuchimoto K, Kobayashi C, Saso W, Kataoka M, Yamasaki M, Kuramochi K, Muramatsu M, Suzuki T, Sureau C, Takeda M, Wakita T, Parhami F, Watashi K. Identification of Anti-Severe Acute Respiratory Syndrome-Related Coronavirus 2 (SARS-CoV-2) Oxysterol Derivatives In Vitro. International journal of molecular sciences. 2021.03; 22 (6): ( PubMed, DOI )

  9. Shionoya K, Yamasaki M, Iwanami S, Ito Y, Fukushi S, Ohashi H, Saso W, Tanaka T, Aoki S, Kuramochi K, Iwami S, Takahashi Y, Suzuki T, Muramatsu M, Takeda M, Wakita T, Watashi K. Mefloquine, a Potent Anti-severe Acute Respiratory Syndrome-Related Coronavirus 2 (SARS-CoV-2) Drug as an Entry Inhibitor in vitro. Frontiers in microbiology. 2021; 12 651403. ( PubMed, DOI )

▼全件表示

このページの先頭へ▲